ALS Drug Gets Review for VA Coverage
LAS VEGAS -- Riluzole (Rilutek) should remain on the Veterans Administration formulary as a treatment for patients with amyotrophic lateral sclerosis, despite having only modest benefits and considerable cost, a researcher said here.
Dec 06, 2012